Organigram Global Inc (OGI) Stock AnalysisOGIStock AnalysisOrganigram Global Inc

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

Given the current price of 1.215 and a recent record Q3 revenue of 105.8 million CAD, OrganiGram Holdings Inc appears to be a good buy right now. The company has shown a remarkable turnaround in revenue growth, with a 49% year-over-year increase, and a strong adjusted EBITDA of 13.4 million CAD, reflecting operational improvements. However, the main risk is the recent net loss of 0.9 million CAD in Q2 2026, which raises concerns about profitability stability.